Search Results - "Dartois, C."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Elucidation of Relationship Between Tumor Size and Survival in Non-Small-Cell Lung Cancer Patients Can Aid Early Decision Making in Clinical Drug Development by Wang, Y, Sung, C, Dartois, C, Ramchandani, R, Booth, BP, Rock, E, Gobburu, J

    Published in Clinical pharmacology and therapeutics (01-08-2009)
    “…Four non‐small‐cell lung cancer (NSCLC) registration trials were utilized to develop models linking survival to risk factors and changes in tumor size during…”
    Get full text
    Journal Article
  2. 2

    Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey by Dartois, C., Brendel, K., Comets, E., Laffont, C. M., Laveille, C., Tranchand, B., Mentré, F., Lemenuel‐Diot, A., Girard, P.

    Published in British journal of clinical pharmacology (01-11-2007)
    “…What is already known about this subject • The reviews already published on population pharmacokinetic/pharmacodynamic (PK/PD) analyses have focused on theory…”
    Get full text
    Journal Article
  3. 3

    A Dynamic Model of Hand-and-Foot Syndrome in Patients Receiving Capecitabine by Hénin, E, You, B, VanCutsem, E, Hoff, PM, Cassidy, J, Twelves, C, Zuideveld, KP, Sirzen, F, Dartois, C, Freyer, G, Tod, M, Girard, P

    Published in Clinical pharmacology and therapeutics (01-04-2009)
    “…For the purpose of developing a longitudinal model to predict hand‐and‐foot syndrome (HFS) dynamics in patients receiving capecitabine, data from two large…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Are population pharmacokinetic and/ or pharmacodynamic models adequately evaluated? : A survey of the literature from 2002 to 2004 by BRENDEL, Karl, DARTOIS, Céline, COMETS, Emmanuelle, LEMENUEL-DIOT, Annabelle, LAVEILLE, Christian, TRANCHAND, Brigitte, GIRARD, Pascal, LAFFONT, Céline M, MENTRD, France

    Published in Clinical pharmacokinetics (01-01-2007)
    “…Model evaluation is an important issue in population analyses. We aimed to perform a systematic review of all population pharmacokinetic and/or pharmacodynamic…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease by DARTOIS, Céline, FREYER, Gilles, MICHALLET, Mauricette, HENIN, Emilie, YOU, Benoit, DARLAVOIX, Isabelle, VERMOT-DESROCHES, Claudine, TRANCHAND, Brigitte, GIRARD, Pascal

    Published in Clinical pharmacokinetics (01-01-2007)
    “…Inolimomab, a monoclonal antibody against interleukin (IL)-2Ralpha (CD25) has shown promising results in the treatment of corticosteroid-resistant acute…”
    Get full text
    Journal Article
  9. 9

    Chromatographic resolution of antihypertensive benzopyrans by closed-loop recycling enantioselective high pressure preparative chromatography and their X-ray analysis by Nadler, Guy, Dartois, Catherine, Eggleston, Drake S., Haltiwanger, R.Curtis, Martin, Michel

    Published in Tetrahedron: asymmetry (11-12-1998)
    “…The resolution of (±)- trans-3,4-dihydro-2,2-dimethyl-4-(2-oxopiperidin-1-yl)-2H-pyrano[3,2-c]pyridin-3-ol 1, [1]a potassium channel opener, has been achieved…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12